These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Metformin: new understandings, new uses. Hundal RS; Inzucchi SE Drugs; 2003; 63(18):1879-94. PubMed ID: 12930161 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Lautatzis ME; Goulis DG; Vrontakis M Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298 [TBL] [Abstract][Full Text] [Related]
28. Use of metformin for women with polycystic ovary syndrome. Tang T; Balen AH Hum Reprod Update; 2013; 19(1):1. PubMed ID: 23114640 [No Abstract] [Full Text] [Related]
29. Role of Metformin in Women's Health: Review of Its Current Place in Clinical Practice and Emerging Indications for Future. Sinai Talaulikar V; Tang T; Yasmin E Obstet Gynecol Surv; 2016 May; 71(5):307-17. PubMed ID: 27182828 [TBL] [Abstract][Full Text] [Related]
30. In support of metformin use in adolescent polycystic ovary syndrome. Mulchahey KM J Pediatr Adolesc Gynecol; 2002 Apr; 15(2):109-11. PubMed ID: 12057535 [No Abstract] [Full Text] [Related]
31. Metformin in 2019. Flory J; Lipska K JAMA; 2019 May; 321(19):1926-1927. PubMed ID: 31009043 [TBL] [Abstract][Full Text] [Related]
35. Metformin in obstetric and gynecologic practice: a review. McCarthy EA; Walker SP; McLachlan K; Boyle J; Permezel M Obstet Gynecol Surv; 2004 Feb; 59(2):118-27. PubMed ID: 14752300 [TBL] [Abstract][Full Text] [Related]
36. Editorial: Metformin--comparison with other therapies in ovulation induction in polycystic ovary syndrome. Norman RJ J Clin Endocrinol Metab; 2004 Oct; 89(10):4797-800. PubMed ID: 15472165 [No Abstract] [Full Text] [Related]
37. Evaluation of guidelines on diabetes medication. Giaccari A; Giorda CB; Riccardi G; De Micheli A; Bruno G; Monge L; Frontoni S Ann Intern Med; 2012 May; 156(10):752-3; author reply 753. PubMed ID: 22586015 [No Abstract] [Full Text] [Related]
38. Evaluation of guidelines on diabetes medication. Brown K; Harbour R; Petrie J Ann Intern Med; 2012 May; 156(10):752; author reply 753. PubMed ID: 22586014 [No Abstract] [Full Text] [Related]
39. Does metformin improve polycystic ovary syndrome symptoms through reduction in body iron stores? Mascitelli L; Pezzetta F Eur J Endocrinol; 2008 Mar; 158(3):439; author reply 441. PubMed ID: 18299480 [No Abstract] [Full Text] [Related]
40. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients. del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; López-Menchero R Nefrologia; 2012; 32(6):837-8; author reply 388-9. PubMed ID: 23169370 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]